The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Standards of Medical Care in Diabetes–2006
Open accessAbstract
Ͻ3.0 mmol/l.Only 49% of the study's diabetic subjects were free of overt CVD, and 19% had prior myocardial infarction.The CARDS (Collaborative Atorvastatin Diabetes Study) (4) showed cardiovascular benefit of statin therapy for LDL Ͼ3.1 mmol/l or Ͻ3.1 mmol/l.Subjects were without CVD but had at least one of hypertension, retinopathy, proteinuria, or smoking.I believe the more appropriate interpretation of these two studies is that cardiovascular benefits of the statin therapy on diabetic patients have been shown for LDL Ͻ or Ͼ3.1 mmol/l (or 3.0 mmol/l, depending on the study).However, the precise lower limit of LDL, where the cardiovascular benefits may or may not persist, has not been explored.Using a threshold of 3.0 mmol/l for LDL is not a replacement for using successively lower thresholds.Using an allegory may help.For example, one cannot claim that since antihypertensive therapy reduces cardiovascular events for patients with blood pressure of Ͼ160/100 mmHg, as well as Ͻ160/100 mmHg, antihypertensive medications should be used regardless of any baseline blood pressure.Our current ignorance of the lowest LDL threshold of statin's benefits should not be replaced by the statement that no lower limit to the benefit of LDL lowering exists.A recent study (5) not referenced in the position statement showed cardiovascular benefit of lowering LDL from 3.3 to 2.15 mmol/l, but again, it does not provide an answer as to whether unlimited lowering of LDL may cease to be useful (6).Hence, I would recommend amending the statement, "For those over the age of 40 years, statin therapy to achieve an LDL reduction of 30 -40%, regardless of baseline LDL levels, is recommended (A)."This can be replaced by "For those over the age of 40 years, without overt CVD or cardiovascular risk factors other than diabetes, statin therapy to lower LDL from Ͼ3.0 mmol/l to Ͻ3.0 mmol/l is advisable.The lowest baseline LDL where statin therapy might cease to be of benefit is currently unexplored and therefore unknown."
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Standards of Medical Care in Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s4 · Cited by 1,885
Standards of Medical Care in Diabetes–2006
Tseng, K. H. (2006) · Diabetes Care · doi:10.2337/dc06-0805 · Cited by 1,092
Cited by
Psychological conditions in adults with diabetes.
de Groot, M., Golden, S. H., & Wagner, J. (2016) · American Psychologist · doi:10.1037/a0040408 · Cited by 170
Sherr, J. L., Heinemann, L., Fleming, G. A., Bergenstal, R. M., Bruttomesso, D., Hanaire, H., Holl, R. W., Petrie, J. R., Peters, A. L., & Evans, M. (2022) · Diabetes Care · doi:10.2337/dci22-0018 · Cited by 136
Diabetes Prevention Program Research Group, Nathan, D. M., Knowler, W. C., Edelstein, S., Crandall, J. P., Dabelea, D., Goldberg, R. B., Kahn, S. E., Mather, K. J., Trandafirescu, G., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1970 · Cited by 128
Lee, A. K., Lee, C. J., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2017) · Diabetes Care · doi:10.2337/dc17-0819 · Cited by 119
(2018) · doi:10.15620/cdc:82212 · Cited by 40
Metadata
- Authors
- Fonseca, V., & Clark, N. G.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-11-01
- Volume
- 29
- Issue
- 11
- Pages
- 2564-2565
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2059350047
- Cited by
- 273
- References
- 4
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.